With 25 years of experience, Marc Beer has shown good leadership that has led to many advances in biotechnology. His work has resulted in the creation of products that help people with rare diseases from around the world. He was able to start the company called ViaCell in 2000. The company collects and preserve stem cells. As the CEO of ViaCell, Beer helped ViaCell create business growth, and the personnel grew to nearly 300 employees. He also was apart of the Board of Directors of a biopharmaceutical company called Erytech. Beer held a variety of positions that involved in sales and marketing while working at Abbott Laboratories. Throughout his career, Beer has been on several different boards of directors such as the Chairman of the Board of a company called Good Start Genetics Incorporated. Beer has been able to provide advice while he was a member of the Notre Dame Research and Commercialization Advisory Committee. In 2016, Beer became the co-founder of Renovia. He successfully receives funding for Series A from venture capital funds that are focused on healthcare. Beer has acted as a strategic consultant for a company called OvaScience. Beer received his college education from Miami University of Ohio.
The CEO Marc Beer was able to lead the company Renovia Incorporated to obtain $32 million Series B round of funding. The company operates out of Boston, Massachusetts. Beer helped acquire $10 million in venture debt for the company. The funding received will go towards creating products to treat pelvic floor disorders. The beer has been able to help the company develop products that treat the pelvic floor disorders such as urinary incontinence that affects nearly 250 million people. A company called the Longwood Fund have made Investments in Renovia, and it would be a part of the series B round along with perspective advisors based in New York and Ascension Ventures based in Missouri. Beer used the funding to develop diagnostic products that will help women with pelvic floor disorders. The funding will also help create a new version of a device called the Leva device. It would be able to get data that allows different treatment options. Renovia guided by Beer will help educate the people regarding pelvic floor disorders. Beer led Renovia to reduce long term healthcare cost with its’ work that will improve the care of people suffering from pelvic floor disorders.
Beer has plenty of investors who believe in the work that’s been developed by Renovia. With investors help, they will be able to improve treatments. The leadership of Beer helped Renovia get a product approved by the FDA. Renovia has been able to develop new treatments and sensor technology to combat pelvic floor disorders. Learn more: https://www.crunchbase.com/person/marc-beer